Geriatric Pharmacoepidemiology

(095) Phosphodiesterase Type 5 Inhibitors and The risk of Alzheimer’s Disease in Men with Erectile Dysfunction: A cohort study

(096) N-Domain vs. C-Domain Angiotensin Converting Enzyme-inhibitors and the risk of Alzheimer's disease: A cohort study

(097) Adverse Drug Reactions in an Ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients

(098) Efficacy and safety of Mixed MAOB Inhibitors in Treatment of Adults with Parkinson's Disease: A Systematic Review and Meta-analysis

(099) Individual contributions of medications with anticholinergic side effects to high anticholinergic burden in older adults

(100) Trends in the Use and Costs of Benzodiazepines and Z-drugs in Canada from 2016 to 2022: a National Repeated Cross-Sectional Study

(101) Concurrent Use of Central Nervous System-Acting Medications and Risk for Inpatient Psychiatric and Skilled Nursing Facility Admission Among Young-onset Alzheimer’s Patients

(102) Trends in prevalence of polypharmacy and hyper-polypharmacy in the UK primary care: a population-based study from 1999 to 2018

(103) Medication Regimen Complexity and Family Caregiver Medication Administration Hassle in Home Hospice

(104) Association of physician characteristics and their competency on prescribing of non-steroidal anti-inflammatory drugs (NSAIDs) among patients with congestive heart failure (CHF)

(105) Describing Adjuvant Chemotherapy Delivery in Older and Younger Women with Early-Stage Breast Cancer Using Longitudinal Cumulative Dose

(106) Association between antibiotics use and encephalopathies-related hospitalization among people living with dementia- a self-controlled case series study

(107) An investigation of psychoactive polypharmacy and related sex-differences in older adults with dementia

(108) Trends in Concurrent Use of Central Nervous System-Active Medications Among Young-onset Dementia Patients

(109) Potentially inappropriate prescribing and its association with adverse drug reaction-related hospital admissions

(110) Patterns of Antibiotic Prescribing for Urinary Tract Infections and Pneumonia by Provider Specialty in Nursing Home Care

(111) Who You Are And Where You Are Influences Antipsychotic Use in People with Dementia Living in Nursing Homes

(112) Pilot Project to Deprescribe Sedative-Hypnotic Drugs to Reduce Risk of Falls in Hospital Patients in Nova Scotia, Canada

(113) Trends in osteoporosis drug initiation and use among community dwelling older adults

(114) Potentially inappropriate medications among elderly patients in Chinese primary healthcare facilities: a nationwide survey, 2017-2019

(115) Drug-Drug Interactions and Adverse Drug Reaction Hospital Admissions in the Older Population: A Prospective Cohort Study

(116) Is willingness enough? Willingness to deprescribe is not associated with changes in medication-related outcomes after one year

(117) Characteristics of seniors undergoing cognitive assessment or with a recent diagnosis of neurocognitive disorders in Quebec Family Medicine Groups in the GPS study

(118) Integrating Social Determinants of Health and Claims Data to Predict a Diagnosis of Depression Using the Medicare Current Beneficiary Survey

(119) Empowering the Elderly Patients: A Study on Impact of Virtual Patient Education on Medication Adherence

(120) Bipolar Disorder Treatment Changes After Nonfatal Suicide Attempt and Association with Subsequent Suicide Attempts: An Analysis of U.S. Veterans

(121) Trends in the prescription of anti-dementia treatments in Spain and the UK: a large network population-based cohort study

(122) Long term Comparative Safety of ARNi verses ACEi/ARB: A Real-World Data analysis

(123) Disparity in guideline-based antidiabetic drugs prescribing for type 2 diabetes patients in primary healthcare facilities across China, 2017-2019

(124) Prescribing Trends of SGLT2 Inhibitors Among Patients with Heart Failure in the U.S., 2013-2020

(125) Validating birth proxy algorithms in Medicaid administrative claims

(126) Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)

(127) Anticoagulant Treatment and Thromboembolic Events Prior to Diagnosis of Renal Cell Carcinoma: Impact on Stage Distribution

(128) Real-World Patterns of Opioid Analgesic, Gabapentinoid, and Benzodiazepine Prescriptions in the United States: A Drug Utilization Study (2017-2021)

(129) Appropriate washout period for adverse events of special interest (AESI) in vaccine active surveillance utilizing an administrative claims database

(130) Association between mortality and warfarin comparing with direct oral anticoagulants: a population-based cohort study

(131) Routine Clinical Use of PD-1/PD-L1 Immune Checkpoint Inhibitors and Survival in Patients With Advanced Cancers: A Danish Population-Based Cohort Study

(132) Validated Algorithms to Identify Non-fatal Strokes using Uniform Objective Criteria: A Pooled Clinical Trial Data Analysis

(133) Sensitivity Analyses to Assess Robustness of Estimates from Propensity Score Weighting in the Presence of Extremely Large Weights

(134) Predictors of Opioid Use Before and After Orthopaedic Surgery in an Australian Setting: A Multicentre, Cross-Sectional, Observational Study

(135) Use Of Baclofen For The Treatment Of Alcohol Use Disorders Between 2014 And 2021 In France

(136) Secular Trends and Determinants of Hepatitis C Virus Testing during Pregnancy

(137) Trends in the Utilisation of Antiepileptic Drugs Following Ischaemic Stroke

(138) Evaluating the Application of a Claims-Based Frailty Algorithm in Younger Adults in the US

(141) Comorbidity clusters before and after adjuvant endocrine therapy in oldest-old women with breast cancer: An unsupervised machine learning approach

(142) Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Dementia in People with Type 2 Diabetes (T2D): A Population-Based Cohort Study

(143) Polypharmacy's association to mortality: A methodological case study

(144) Hip fracture incidence and post-fracture mortality in Victoria, Australia from 2012 to 2018

(145) The European Drug-Drug Interaction (EuroDDI) study protocol: a cross country comparison of the prevalence of drug-drug interactions in the older community-dwelling population

(146) The association of gabapentin initiation and neurocognitive changes in non-demented older adults with cognitive symptoms

(147) Liraglutide and Risk of Dementia: Real World Evidence